Brian Hess to Antibodies, Monoclonal
This is a "connection" page, showing publications Brian Hess has written about Antibodies, Monoclonal.
Connection Strength
0.173
-
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies. Blood. 2023 01 12; 141(2):200-203.
Score: 0.173